Advertisement

Topics

Latest "Placebo Hepatitis Virus Infection" News Stories

01:26 EDT 25th June 2017 | BioPortfolio

Here are the most relevant search results for "Placebo Hepatitis Virus Infection" found in our extensive news archives from over 250 global news sources.

More Information about Placebo Hepatitis Virus Infection on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Placebo Hepatitis Virus Infection for you to read. Along with our medical data and news we also list Placebo Hepatitis Virus Infection Clinical Trials, which are updated daily. BioPortfolio also has a large database of Placebo Hepatitis Virus Infection Companies for you to search.

Showing "Placebo Hepatitis Virus Infection" News Articles 1–25 of 7,400+

Extremely Relevant

Researchers identify how class of drugs blocks Hepatitis C virus replication

Globally, an estimated 71 million people are living with chronic hepatitis C virus (HCV). Over decades of infection, chronic HCV infection results in progressive damage to the liver and an increased risk for end stage liver disease and liver cancer, making the virus the leading cause of liver-related deaths in the United States today.


Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon

Occult hepatitis B infection (OBI) among HIV positive patients varies widely in different geographic regions. We undertook a study to determine the prevalence of occult hepatitis B infection among HIV infected...

Statins may benefit cirrhotic patients with Hepatitis B or C infections

(Wiley) Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) can lead to cirrhosis as well as liver cancer. A Hepatology study from Taiwan has found that statins may provide benefits to patients with HBV- or HCV-related cirrhosis.


New hepatitis data highlight need for urgent global response

New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. The WHO Global hepatitis report, 2017 indicates that the large majority of these people lack access to life-saving testing and treatment. As a result, millions of people are at risk of a slow progression to chronic liver disease, cancer, and deat...

Outbreak of Hepatitis A linked to bakery as nine people hospitalised with liver infection – Mirror.co.uk

Mirror.co.ukOutbreak of Hepatitis A linked to bakery as nine people hospitalised with liver infectionMirror.co.ukAn outbreak of Hepatitis A could be linked to a bakery after nine confirmed cases and nine suspected cases have led investigators to the shop. Hepatitis A is a liver infection caused by a virus that is spread in the poo of an infected person, and is ...Nine people hospitalised with hepa...

Chronic Hepatitis C Virus Infection and Risk for Diabetes

Does chronic hepatitis C infection increase diabetes risk? Liver International

No Consistent Pattern of HBV Reactivation With Direct-acting Antivirals for HCV

The largest case review to date of hepatitis B virus (HBV) reactivation associated with direct-acting antiviral (DAA) therapy for chronic hepatitis C virus (HCV) infection found no consistent pattern in terms of which patients are likely to develop this adverse event. Reuters Health Information

Hepatitis C Virus Genotype 4: Genotype 1's Little Brother

Treatment options for patients with chronic HCV genotype 4 infections continue to expand. What are the currently available and investigative treatments for HCV GT4 infection? Journal of Viral Hepatitis

Statins may provide favorable outcomes to patients with HBV- or HCV-related cirrhosis

Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) can lead to cirrhosis as well as liver cancer. A Hepatology study from Taiwan has found that statins may provide benefits to patients with HBV- or HCV-related cirrhosis.

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) can lead to cirrhosis as well as liver cancer. A Hepatology study from Taiwan has found that statins may provide benefits to patients with HBV- or HCV-related cirrhosis.

MRC Licenses Hepatitis C Antibody to China

UK medical research charity MRC Technology has licensed an antibody to Newsummit Biopharma, a leading Chinese drug developer, in an effort to create a novel therapeutic for treating Hepatitis C virus (HCV) infection.

New interferon shows promise against hepatitis B in cell culture, and animal model

Hepatitis B is notoriously difficult to eradicate with currently available agents.. Now, in a new study, a novel form of "pegylated" interferon-β has reduced hepatitis B virus (HBV) infections in experimental human-derived cells and in mice more effectively than the conventional pegylated interferon-α2a, suggesting that it could lead to improved treatment for hepatitis B infection in humans. The...

Report: Hepatitis C Rates on the Rise Among Reproductive-aged Women

The incidence of hepatitis C virus infection has increased among young people who inject drugs, about half of whom are women of reproductive age, according to the CDC.

Scientists step closer to drug treatment for hepatitis B

A major new insight into how Hepatitis B Virus works could pave the way for new drug treatments for the infection which is the major cause of liver cancer worldwide.

Hepatitis C treatment: Genes found that calibrate how our immune system affects virus

HBV reactivation seen with DAA treatment of chronic hep C

(HealthDay)—For patients with chronic hepatitis C (CHC) treated with direct-acting antivirals (DAAs), hepatitis B virus (HBV) reactivation may occur in those with current HBV infection, according to a study published online Feb. 23 in the Journal of Gastroenterology and Hepatology.

Medical News Today: Parkinson's risk may be higher with hepatitis virus infection

Researchers have found that people infected with hepatitis B or C may be at significantly higher risk of developing Parkinson's disease.

Scientists a step closer to drug treatment for hepatitis B

A major new insight into how hepatitis B virus works could pave the way for new drug treatments for the infection which is the major cause of liver cancer worldwide, report scientists.

New EASL clinical practice guidelines on the management of hepatitis B virus

The European Association for the Study of the Liver (EASL) today published their revised Clinical Practice Guidelines (CPGs) on the management of Hepatitis B virus (HBV) infection. The CPGs, which will also be presented in a session at The International Liver Congress 2017 in Amsterdam, The Netherlands, are designed to help physicians and healthcare providers optimise the management of patients wi...

MRC Technology Licenses Antibody To For Development Of Hepatitis C Virus Infection Therapeutic

  Life Sciences Jobs   ...

Hepatitis C Mutations Outrun Immune Systems, Study Shows

Unlike its viral cousins hepatitis A and B, hepatitis C virus (HCV) has eluded the development of a vaccine and infected more than 170 million people worldwide. Now, researchers at Johns Hopkins Medicine report that a novel laboratory tool that lets them find virus mutations faster and more efficiently than ever before has identified a biological

Point-of-care hep C test developed

A research team led by UNSW’s Kirby Institute has evaluated a new test that enables diagnosis of hepatitis C infection in a single visit, with promising results. Their study has been published in The Lancet Gastroenterology & Hepatology. The researchers conducted the first evaluation of the Xpert HCV Viral Load test, manufactured by molecular diagnostics company Cepheid — a point-of-care ...

Hepatitis C virus: Possible new approach to battling infections

An international study has shone light on the way the Hepatitis C Virus (HCV) hijacks the communication systems in the host cells it infects, uncovering potential new therapeutic targets for the disease.

SLU researchers receive $416,000 to further work toward hepatitis B cure

(Saint Louis University) Saint Louis University scientists aim to advance our understanding of how the hepatitis B virus replicates in order to develop a new drug that could cure the viral infection.

Eiger Biopharma Announces U.S. IND Filing Of Pegylated Interferon Lambda For Hepatitis Delta Virus Infection

  Life Sciences Jobs   ...


Quick Search
Advertisement
 

News Quicklinks